Pharmacokinetics of Lopinavir-Ritonavir with and without Nonnucleoside Reverse Transcriptase Inhibitors in Ugandan HIV-Infected Adults

We evaluated the pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors (NNRTIs) in Ugandan adults. The study design was a three-period crossover study (3 tablets [600 mg of lopinavir/150 mg of ritonavir {600/150 mg}], 4 capsules [533/133 mg], and 2 t...

Full description

Saved in:
Bibliographic Details
Main Authors: Kityo, C., Walker, A. S., Dickinson, L., Lutwama, F., Kayiwa, J., Ssali, F., Nalumenya, R., Tumukunde, D., Munderi, P., Reid, A., Gilks, C. F., Gibb, D. M., Khoo, S.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology (ASM) 2010
Subjects:
Pharmacology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897274/
https://ncbi.nlm.nih.gov/pubmed/20421406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01198-09
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items